• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza

tetano

Editor, Senior Moderator
Phytomedicine. 2019 Apr 4;64:152904. doi: 10.1016/j.phymed.2019.152904. [Epub ahead of print]
[h=1]Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.[/h] Huang CT[SUP]1[/SUP], Hung CY[SUP]2[/SUP], Hseih YC[SUP]3[/SUP], Chang CS[SUP]4[/SUP], Velu AB[SUP]5[/SUP], He YC[SUP]4[/SUP], Huang YL[SUP]4[/SUP], Chen TA[SUP]4[/SUP], Chen TC[SUP]6[/SUP], Lin CY[SUP]7[/SUP], Lin YC[SUP]8[/SUP], Shih SR[SUP]5[/SUP], Dutta A[SUP]9[/SUP].
[h=3]Author information[/h] 1 Division of Infectious Diseases, Department of Medicine, Chang Gung Memorial Hospital, Guishan- 33333, Taoyuan City, Taiwan; College of Medicine, Chang Gung University, Guishan-33333, Taoyuan City, Taiwan. 2 Department of Thoracic Medicine, Chang Gung Memorial Hospital, Guishan-33333, Taoyuan City, Taiwan. 3 Division of Pediatric Infectious Diseases, Department of Medicine, Chang Gung Memorial Hospital, Guishan- 33333, Taoyuan City, Taiwan. 4 Division of Infectious Diseases, Department of Medicine, Chang Gung Memorial Hospital, Guishan- 33333, Taoyuan City, Taiwan. 5 Research Center for Emerging Viral Infections and Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Guishan- 33333, Taoyuan City, Taiwan. 6 College of Medicine, Chang Gung University, Guishan-33333, Taoyuan City, Taiwan; Department of Pathology, Chang Gung Memorial Hospital, Guishan-33333, Taoyuan City, Taiwan. 7 College of Medicine, Chang Gung University, Guishan-33333, Taoyuan City, Taiwan; Division of Hepatogastroenterology, Department of Medicine, Chang Gung Memorial Hospital, Guishan- 33333, Taoyuan City, Taiwan. 8 College of Medicine, Chang Gung University, Guishan-33333, Taoyuan City, Taiwan; Division of Hematology and Oncology, Department of Medicine, Chang Gung Memorial Hospital, Guishan- 33333, Taoyuan City, Taiwan. 9 Division of Infectious Diseases, Department of Medicine, Chang Gung Memorial Hospital, Guishan- 33333, Taoyuan City, Taiwan. Electronic address: duttijiva@gmail.com.

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Millions of people are infected by the influenza virus worldwide every year. Current selections of anti-influenza agents are limited and their effectiveness and drug resistance are still of concern.
[h=4]PURPOSE:[/h] Investigation on in vitro and in vivo effect of aloin from Aloe vera leaves against influenza virus infection.
[h=4]METHODS:[/h] In vitro antiviral property of aloin was measured by plaque reduction assay in which MDCK cells were infected with oseltamivir-sensitive A(H1N1)pdm09, oseltamivir-resistant A(H1N1)pdm09, H1N1 or H3N2 influenza A or with influenza B viruses in the presence of aloin. In vivo activity was tested in H1N1 influenza virus infected mice. Aloin-mediated inhibition of influenza neuraminidase activity was tested by MUNANA assay. Aloin treatment-mediated modulation of anti-influenza immunity was tested by the study of hemagglutinin-specific T cells in vivo.
[h=4]RESULTS:[/h] Aloin significantly reduced in vitro infection by all the tested strains of influenza viruses, including oseltamivir-resistant A(H1N1)pdm09 influenza viruses, with an average IC[SUB]50[/SUB] value 91.83 ? 18.97 μM. In H1N1 influenza virus infected mice, aloin treatment (intraperitoneal, once daily for 5 days) reduced virus load in the lungs and attenuated body weight loss and mortality. Adjuvant aloin treatment also improved the outcome with delayed oseltamivir treatment. Aloin inhibited viral neuraminidase and impeded neuraminidase-mediated TGF-β activation. Viral neuraminidase mediated immune suppression with TGF-β was constrained and influenza hemagglutinin-specific T cell immunity was increased. There was more infiltration of hemagglutinin-specific CD4+ and CD8+ T cells in the lungs and their production of effector cytokines IFN-γ and TNF-α was boosted.
[h=4]CONCLUSION:[/h] Aloin from Aloe vera leaves is a potent anti-influenza compound that inhibits viral neuraminidase activity, even of the oseltamivir-resistant influenza virus. With suppression of this virus machinery, aloin boosts host immunity with augmented hemagglutinin-specific T cell response to the infection. In addition, in the context of compromised benefit with delayed oseltamivir treatment, adjuvant aloin treatment ameliorates the disease and improves survival. Taken together, aloin has the potential to be further evaluated for clinical applications in human influenza.
Copyright ? 2019 Elsevier GmbH. All rights reserved.


[h=4]KEYWORDS:[/h] Aloe vera; Aloin; Hemagglutinin-specific T cell immunity; Influenza; Viral neuraminidase; Virus load

PMID: 31454654 DOI: 10.1016/j.phymed.2019.152904
 
Back
Top Bottom